OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CXL57

Calix Ltd

Commodity ChemicalsVerified

Calix Ltd's capital structure is characterized by a lack of detailed liquidity metrics, as liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot does not provide specific ratios for further analysis. In terms of profitability, there is no available data to compare Calix Ltd's performance against industry_config preferred metrics or cohort medians. This lack of data limits the ability to assess the company's profitability and returns relative to its peers. Calix Ltd's segments and geographic exposure are not detailed in the provided data, making it difficult to evaluate revenue concentration or geographic diversification. The company's exposure to specific markets or regions is not disclosed. The growth trajectory of Calix Ltd is not quantified in the provided data, as there are no numeric deltas or revenue history to indicate the company's current or future growth. The outlook for the company's financial performance is not specified. Risk factors for Calix Ltd include a low dilution potential, as indicated by the risk assessment. However, the lack of detailed financial data and the absence of going-concern language in source documents suggest that the company may face liquidity challenges. No specific dilution sources or expected timeframes are provided. Recent events related to Calix Ltd are not detailed in the provided data. There are no specific filings or transcripts mentioned that would provide insight into the company's recent activities or strategic direction.

30-day price · CXL-0.02 (-2.8%)
Low$0.45High$0.80Close$0.52As of12 May, 00:00 UTC
Profile
CompanyCalix Ltd
TickerCXL.AX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Calix Ltd is a chemical company that produces and sells industrial chemicals, primarily serving the water treatment and construction industries.

Classification. Calix Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Calix Ltd's capital structure is characterized by a lack of detailed liquidity metrics, as liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot does not provide specific ratios for further analysis. In terms of profitability, there is no available data to compare Calix Ltd's performance against industry_config preferred metrics or cohort medians. This lack of data limits the ability to assess the company's profitability and returns relative to its peers. Calix Ltd's segments and geographic exposure are not detailed in the provided data, making it difficult to evaluate revenue concentration or geographic diversification. The company's exposure to specific markets or regions is not disclosed. The growth trajectory of Calix Ltd is not quantified in the provided data, as there are no numeric deltas or revenue history to indicate the company's current or future growth. The outlook for the company's financial performance is not specified. Risk factors for Calix Ltd include a low dilution potential, as indicated by the risk assessment. However, the lack of detailed financial data and the absence of going-concern language in source documents suggest that the company may face liquidity challenges. No specific dilution sources or expected timeframes are provided. Recent events related to Calix Ltd are not detailed in the provided data. There are no specific filings or transcripts mentioned that would provide insight into the company's recent activities or strategic direction.
Key takeaways
  • Calix Ltd operates in the Commodity Chemicals industry, focusing on industrial chemicals for water treatment and construction.
  • The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
  • There is no available data to compare Calix Ltd's profitability and returns against industry metrics or cohort medians.
  • The company's segments, geographic exposure, and growth trajectory are not detailed in the provided data.
  • Calix Ltd has a low dilution potential, but the lack of detailed financial data suggests potential liquidity challenges.
  • # RATIONALES
  • margin_outlook_rationale: No data is available to determine the direction or driver of Calix Ltd's margin outlook.
  • rd_outlook_rationale: No data is available to determine the direction or driver of Calix Ltd's research and development outlook.
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$29.9M-$8.9M-$9.1M-$12.8M
FY-3$20.8M-$16.7M-$16.3M-$21.3M
FY-2$29.6M-$23.1M-$23.2M-$30.6M
FY-1$29.5M-$25.7M-$25.3M-$38.2M
FY0$33.1M-$20.5M-$19.2M-$22.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$51.6M$38.1M
FY-3$61.2M$43.5M
FY-2$127.5M$103.7M
FY-1$112.4M$83.8M
FY0$110.4M$88.3M
PeriodOCFCapExFCFSBC
FY-4-$8.1M-$6.9M-$12.8M
FY-3-$3.7M-$9.0M-$21.3M
FY-2-$17.3M-$13.0M-$30.6M
FY-1-$13.7M-$19.4M-$38.2M
FY0-$28.7M-$10.9M-$22.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricCXLActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Observations
IR observations
Mean price target2.05 AUD
Median price target2.05 AUD
High price target2.40 AUD
Low price target1.70 AUD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.04 AUD
Last actual EPS-0.10 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:51 UTC#a95f6639
Market quoteclose AUD 0.56 · shares 0.22B diluted
no public URL
2026-05-10 09:51 UTC#120ae735
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 17:48 UTCJob: cc70ee57